NCT05558644View on ClinicalTrials.gov

Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) (IMMUNO-TET)

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 3, 2023

Primary Completion Date

October 5, 2026

Study Completion Date

October 5, 2026

Conditions
Cancer
Interventions
OTHER

single arm for all patients

"* tumor samples will be taken for RNA sequencing of epithelial tumour cells during surgery.~* blood samples will be taken for Exome Sequencing (WES) at baseline, during surgery and one month post surgery."

Trial Locations (3)

Unknown

RECRUITING

Institut Curie Paris, Paris

RECRUITING

Institut Mutualiste Montsouris, Paris

RECRUITING

Hôpital FOCH, Suresnes

All Listed Sponsors
lead

Institut Curie

OTHER